An Open-Label Phase II Study Evaluating the Safety and Efficacy of Ramucirumab Combined With mFOLFOX-6 as First-Line Therapy for Metastatic Colorectal Cancer
NAGIOS: RODERIC FUNCIONANDO

An Open-Label Phase II Study Evaluating the Safety and Efficacy of Ramucirumab Combined With mFOLFOX-6 as First-Line Therapy for Metastatic Colorectal Cancer

DSpace Repository

An Open-Label Phase II Study Evaluating the Safety and Efficacy of Ramucirumab Combined With mFOLFOX-6 as First-Line Therapy for Metastatic Colorectal Cancer

Show full item record

View       (640.0Kb)

Exportar a Refworks
    
Garcia-Carbonero, Rocio; Rivera, Fernando; Maurel, Joan; Ayoub, Jean-Pierre M.; Moore, Malcolm J.; Cervantes Ruipérez, Andrés; Asmis, Timothy R.; Schwartz, Jonathan D.; Nasroulah, Federico; Ballal, Shaila; Tabernero, Josep
This document is a artículoDate2014

    The Oncologist Vol. 19 Issue 4: pp. 350-351
distribuido bajo licencia Creative Commons de Reconocimiento-NoComercial 3.0 No adaptada

This item appears in the following Collection(s)

Show full item record

Search DSpace

Advanced Search

Browse

Statistics